Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.320
+0.050 (3.94%)
At close: Jan 21, 2025, 4:00 PM
1.330
+0.010 (0.76%)
After-hours: Jan 21, 2025, 6:20 PM EST
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $150.34 million as of January 21, 2025. Its market cap has decreased by -56.93% in one year.
Market Cap
150.34M
Enterprise Value
-47.60M
1-Year Change
-56.93%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $150.34M, an increase of 19.22%. That is a compound annual growth rate of 1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 144.60M | -23.04% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |